D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 57 Citations 10,872 123 World Ranking 1337 National Ranking 7
Medicine D-index 80 Citations 21,185 310 World Ranking 9641 National Ranking 22

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Tuberculosis
  • Acquired immunodeficiency syndrome

Gavin J. Churchyard mainly focuses on Tuberculosis, Immunology, Internal medicine, Acquired immunodeficiency syndrome and Surgery. He is interested in Mycobacterium tuberculosis, which is a field of Tuberculosis. His Immunology study combines topics from a wide range of disciplines, such as Efavirenz and Virology.

As a part of the same scientific study, he usually deals with the Internal medicine, concentrating on Sputum and frequently concerns with Relative risk. Gavin J. Churchyard interconnects Cross-sectional study, Viral load, Public health and Risk factor in the investigation of issues within Acquired immunodeficiency syndrome. His studies deal with areas such as Mass screening, Comorbidity and Isoniazid as well as Surgery.

His most cited work include:

  • The diarylquinoline TMC207 for multidrug-resistant tuberculosis. (633 citations)
  • The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study (417 citations)
  • HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. (416 citations)

What are the main themes of his work throughout his whole career to date?

Tuberculosis, Internal medicine, Immunology, Acquired immunodeficiency syndrome and Surgery are his primary areas of study. His Tuberculosis research is multidisciplinary, incorporating perspectives in Incidence, Pediatrics and Intensive care medicine. His biological study spans a wide range of topics, including Intervention, Disease and Transmission.

His research integrates issues of Psychological intervention and Virology in his study of Immunology. His work carried out in the field of Acquired immunodeficiency syndrome brings together such families of science as Epidemiology, Health care, Cohort study and Public health. His Surgery research incorporates themes from Silicosis and Mass screening.

He most often published in these fields:

  • Tuberculosis (83.06%)
  • Internal medicine (37.50%)
  • Immunology (33.06%)

What were the highlights of his more recent work (between 2018-2021)?

  • Tuberculosis (83.06%)
  • Internal medicine (37.50%)
  • Sputum (16.39%)

In recent papers he was focusing on the following fields of study:

Gavin J. Churchyard mostly deals with Tuberculosis, Internal medicine, Sputum, Environmental health and Disease. Gavin J. Churchyard undertakes interdisciplinary study in the fields of Tuberculosis and Spirometry through his works. His Internal medicine research includes elements of Multiple drug resistance and Mycobacterium tuberculosis.

The concepts of his Environmental health study are interwoven with issues in Extensively drug-resistant tuberculosis, Mortality rate, Epidemiology and Psychological intervention. The study incorporates disciplines such as Research design and Incidence in addition to Disease. His Prospective cohort study research is multidisciplinary, incorporating elements of Immunology and Respiratory system.

Between 2018 and 2021, his most popular works were:

  • Building a tuberculosis-free world: The Lancet Commission on tuberculosis (118 citations)
  • The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis. (32 citations)
  • Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis. (24 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Acquired immunodeficiency syndrome

His primary scientific interests are in Tuberculosis, Sputum, Cohort study, Intervention and Intensive care medicine. His study in Tuberculosis is interdisciplinary in nature, drawing from both Disease progression, Internal medicine, Disease and Hazard ratio. When carried out as part of a general Internal medicine research project, his work on Odds ratio, Clinical trial and Meta-analysis is frequently linked to work in Nucleic acid amplification technique, therefore connecting diverse disciplines of study.

His Sputum study incorporates themes from Test, Case definition, Medical physics and Generalizability theory. His research in Intervention intersects with topics in Demand creation, Tuberculosis prevention, Cause of death, Transmission and Public health. His Intensive care medicine study integrates concerns from other disciplines, such as Regimen, Pharmacotherapy, Bedaquiline, Pretomanid and Dosing.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The diarylquinoline TMC207 for multidrug-resistant tuberculosis.

Andreas H. Diacon;Alexander Pym;Martin Grobusch;Ramonde Patientia.
The New England Journal of Medicine (2009)

908 Citations

HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response.

Salim Safurdeen. Abdool Karim;Salim Safurdeen. Abdool Karim;Gavin J. Churchyard;Quarraisha. Abdool Karim;Quarraisha. Abdool Karim;Stephen D. Lawn.
The Lancet (2009)

639 Citations

Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment.

Elizabeth L Corbett;Elizabeth L Corbett;Barbara Marston;Gavin J Churchyard;Kevin M De Cock;Kevin M De Cock.
The Lancet (2006)

585 Citations

The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study

Wouter Hoefsloot;Jakko Van Ingen;Claire Andrejak;Kristian Ängeby.
European Respiratory Journal (2013)

584 Citations

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

Keertan Dheda;Tawanda Gumbo;Gary Maartens;Kelly E. Dooley.
The Lancet Respiratory Medicine (2017)

432 Citations

Achieving the health Millennium Development Goals for South Africa: challenges and priorities

Mickey. Chopra;Mickey. Chopra;Joy E. Lawn;Joy E. Lawn;David. Sanders;Peter. Barron.
The Lancet (2009)

429 Citations

Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies.

Haileyesus Getahun;Wanitchaya Kittikraisak;Charles M. Heilig;Elizabeth L. Corbett.
PLOS Medicine (2011)

421 Citations

High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis

Amina Jindani;Thomas S. Harrison;Andrew J. Nunn;Patrick P.J. Phillips.
The New England Journal of Medicine (2014)

385 Citations

Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.

Glenda E. Gray;Mary. Allen;Zoe. Moodie;Gavin J. Churchyard.
Lancet Infectious Diseases (2011)

371 Citations

Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment

Eva Hnizdo;Tanusha Singh;Gavin Churchyard.
Thorax (2000)

333 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Gavin J. Churchyard

Stephen D. Lawn

Stephen D. Lawn

University of London

Publications: 127

Robin Wood

Robin Wood

University of Cape Town

Publications: 112

Robert J. Wilkinson

Robert J. Wilkinson

The Francis Crick Institute

Publications: 111

Alimuddin Zumla

Alimuddin Zumla

University College London

Publications: 101

Keertan Dheda

Keertan Dheda

University of Cape Town

Publications: 92

Elizabeth L. Corbett

Elizabeth L. Corbett

University of London

Publications: 81

Giovanni Battista Migliori

Giovanni Battista Migliori

Queen Mary University of London

Publications: 74

Graeme Meintjes

Graeme Meintjes

University of Cape Town

Publications: 71

Anthony D. Harries

Anthony D. Harries

International Union Against Tuberculosis and Lung Disease

Publications: 61

Ben J. Marais

Ben J. Marais

Children's Hospital at Westmead

Publications: 61

Ibrahim Abubakar

Ibrahim Abubakar

University College London

Publications: 56

Madhukar Pai

Madhukar Pai

McGill University

Publications: 51

Richard E. Chaisson

Richard E. Chaisson

Johns Hopkins University

Publications: 51

Gary Maartens

Gary Maartens

University of Cape Town

Publications: 50

Georgia D. Tomaras

Georgia D. Tomaras

Duke University

Publications: 47

David C. Montefiori

David C. Montefiori

Duke University

Publications: 47

Trending Scientists

Robert Weibel

Robert Weibel

University of Zurich

Bernhard Pfahringer

Bernhard Pfahringer

University of Waikato

Guglielmo Weber

Guglielmo Weber

University of Padua

Adrian David Cheok

Adrian David Cheok

i-University Tokyo

Peter L. Douglas

Peter L. Douglas

University of Waterloo

Lih Y. Lin

Lih Y. Lin

University of Washington

Xue-Qing Gong

Xue-Qing Gong

East China University of Science and Technology

Ryszard Amarowicz

Ryszard Amarowicz

Polish Academy of Sciences

Erik Schlangen

Erik Schlangen

Delft University of Technology

Michael Weinfeld

Michael Weinfeld

University of Alberta

David R. Brown

David R. Brown

University of Bath

Donald E. Woods

Donald E. Woods

University of Calgary

Daniel Senkowski

Daniel Senkowski

Charité - University Medicine Berlin

Eva H. Telzer

Eva H. Telzer

University of North Carolina at Chapel Hill

Freda Newcombe

Freda Newcombe

University of Oxford

Dennis C. Sgroi

Dennis C. Sgroi

Harvard University

Something went wrong. Please try again later.